Thomas Haberer

TL;DR: Carbon ion therapy is safe with respect to toxicity and offers high local control rates for skull base tumors such as chordomas, low-grade chondrosarcomas, and unfavorable adenoid cystic carcinomas.

TL;DR: In this paper, the first in-beam PET measurements of the beta+ activation induced by proton irradiation are presented, which supports the feasibility of an in- situ proton therapy monitoring by means of PET, as already clinically implemented for the monitoring of carbon ion therapy at GSI Darmstadt.

TL;DR: In this article, an ion beam therapy system comprising a plurality of separate patient treatment stations, a source of ions, an accelerator system for accelerating ions as a beam and a gantry transport system for directing the ion beam from the accelerator to the treatment stations is presented.

TL;DR: The ion beam therapy facility presently under construction at the Department of Clinical Radiology, University of Heidelberg, Germany, will be the first dedicated and hospital-based irradiation facility for protons and heavier ions in Europe.

TL;DR: Information and guidelines for the start-up and clinical operation of forthcoming ion beam therapy facilities similar to HIT are provided and MC dose calculations of planned treatments in water are shown to represent a valuable tool for supporting treatment plan verification in comparison to dosimetric measurements.